Your browser doesn't support javascript.
loading
Use of recombinant factor VIIa in uncontrolled gastrointestinal bleeding after hematopoietic stem cell transplantation among patients with thrombocytopenia
Pakistan Journal of Medical Sciences. 2015; 31 (6): 1389-1393
en Inglés | IMEMR | ID: emr-175114
ABSTRACT
Background and

Objective:

Recombinant-activated factor VII [rVIIa] is a vitamin K-dependent glycoprotein that is an analog of the naturally occurring protease. It has an off-label use to control life-threatening bleeding that is refractory to other measures and was shown to decrease transfusion requirements. Gastrointestinal [GI] bleeding is a severe complication following hematopoietic stem cell transplantation [HSCT] in patients with thrombocytopenia, while hemostatic measures based on antifibrinolytic or transfusion therapy may not always be successful. The present study investigated the treatment with rFVIIa in severe GI bleeding among thrombocytopenia patients undergoing HSCT
Asunto(s)
Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Asunto principal: Trombocitopenia / Proteínas Recombinantes / Hemorragia Gastrointestinal Límite: Adulto / Femenino / Humanos / Masculino Idioma: Inglés Revista: Pak. J. Med. Sci. Año: 2015

Similares

MEDLINE

...
LILACS

LIS

Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Asunto principal: Trombocitopenia / Proteínas Recombinantes / Hemorragia Gastrointestinal Límite: Adulto / Femenino / Humanos / Masculino Idioma: Inglés Revista: Pak. J. Med. Sci. Año: 2015